Xigduo XR contains a combination of dapagliflozin and metformin. Dapagliflozin and metformin are oral diabetes medicines that help control blood sugar levels. Dapagliflozin works by helping the kidneys get rid of glucose from your bloodstream. Metformin lowers glucose production in the liver and also causes your intestines to absorb less glucose. Xigduo XR is used together with diet and exercise to treat type 2 diabetes. Dapagliflozin is not for treating type 1 diabetes. Xigduo XR may also be used for purposes not listed in this medication guide.
Xigduo XR is made up of metformin and dapagliflozin. Metformin and Dapagliflozin are oral diabetes drugs that assist in controlling blood sugar levels. Dapagliflozin does work by helping the kidneys eliminate glucose from your bloodstream. Metformin decreases glucose production in the liver and also makes your intestines take in less glucose. Xigduo XR is taken together with diet plus exercise to treat type 2 Diabetes. Dapagliflozin doesn't treat type 1 diabetes. Xigduo XR can also be used for functions not included in this medication guidebook.
Xigduo XR is a medication used in various parts of the world. It consists of metformin and dapagliflozin as oral diabetes medication mainly used to control the blood sugar levels. Metformin’s function is to lower the production of the glucose in the liver and ensure minimal absorption of glucose in the intestines.
On the other hand, Dapagliflozin assists the kidneys in getting rid of glucose from the bloodstream. Xigduo XR is used jointly with exercise and diet to treat type II diabetes. The control of high blood sugar in the body helps in prevention of blindness, kidney damage, loss of limbs, and nerve problems. It has also been proven that the practice lowers the risk of heart attacks as well as stroke.
Xigduo XR, therefore, works by ensuring restoration of the body’s quality response to the insulin it naturally produces, increasing the removal of sugars by the kidneys. However, this medication should not be used by people with moderate to severe kidney disease. It should be used as prescribed by the medical healthcare provider to eliminate the risks of uncertainty.